![108150023 108150023](https://api.time.com/wp-content/uploads/2015/02/108150023-copy.jpg?quality=85&w=2400)
The personal genomics company 23andMe has identified 35 genetic factors tied to motion sickness, according to a new study published in the journal Human Molecular Genetics.
In what the company says is the first ever genome-wide study looking at motion sickness, 23andMe was able to determine several genes that may be tied to the nausea associated with movement in a car or on a boat. Motion sickness affects around one in three people, and prior research has suggested that it could be hereditary.
The researchers, who are employed by 23andMe (or have been in the past) and own stock options in the company, used genetic data from more than 80,000 23andMe customers. They found that many of these genetic factors were involved in balance, eye and ear development and the nervous system. Overall, the effect appeared to be stronger in women.
Read more: Genetic Testing Company 23andMe Finds New Revenue With Big Pharma
The study also found links between risk for motion sickness and a greater likelihood of having migraines, morning sickness and vertigo.
It’s still unclear what the actual drivers are, and even if a person has the gene variants linked to motion sickness, it doesn’t mean they will definitely have the condition. Genome-wide association studies like the one performed by 23andMe can only find correlations, but they’re still useful strategies for finding at-risk genes.
More Must-Reads from TIME
- Eyewitness Accounts From the Trump Rally Shooting
- Politicians Condemn Trump Rally Shooting: ‘No Place for Political Violence in Our Democracy’
- From 2022: How the Threat of Political Violence Is Transforming America
- ‘We’re Living in a Nightmare:’ Inside the Health Crisis of a Texas Bitcoin Town
- Remembering Shannen Doherty , the Quintessential Gen X Girl
- How Often Do You Really Need to Wash Your Sheets?
- Welcome to the Noah Lyles Olympics
- Get Our Paris Olympics Newsletter in Your Inbox
Contact us at letters@time.com